UTILIGENSIA LIMITED Financials
- Company number
- 04562129CopyCopy
- Registered office
- Suite 20-21 Azure Business Centre High Street, Newburn, Newcastle Upon Tyne NE15 8LN
- Incorporated
- 14/10/2002
Company snapshot
- Status
- Active
- Employees
- 0 (2025)
- Latest financial data
- 2025
- Accounts type
- Micro Entity
Financial highlights
Latest reported figures. Okredo holds filed data for 2021–2025.
Net Assets
2024: £7.26K
Total Assets
2024: £61.92K
Total Liabilities
2024: £54.65K
Employees
2024: 0
In 2025, UTILIGENSIA LIMITED reported net assets of £-13.13K. The same filing shows total assets of £127.07K and total liabilities of £140.19K. Reported headcount was 0 in 2025. Total Liabilities rose from £54.65K in 2024 to £140.19K in 2025 (156.52%). Okredo holds filed figures for 2021–2025; the table below lists every reported indicator by year. See every reported indicator by year.
Financial performance
Pick a measure to see how it has moved across the reported years, with the year-on-year change beneath it.
Net Assets
Year-on-year change
Net Assets as filed for 2021–2025. Every figure in this chart is also in the financial history table.
3-year financial trend (2023–2025)
How the figures UTILIGENSIA LIMITED filed moved across the three reported years 2023, 2024 and 2025 — measured end to end rather than year on year.
Net Assets
Total Assets
+33.2% a year compound (CAGR)
Employees
Biggest increase
Total Assets+77.5%
£71.58K in 2023 to £127.07K in 2025
Biggest decrease
Net Assets-165%
£20.06K in 2023 to £-13.13K in 2025
UTILIGENSIA LIMITED's filings pull in both directions between 2023 and 2025. The steepest rise came in total assets, pointing to a broader asset base, set against a fall in net assets, pointing to a weakening balance sheet. See the full year-by-year figures.
Ratios from the filed figures
Calculated from UTILIGENSIA LIMITED's own reported amounts, each shown against the year it was derived from — nothing here is estimated or industry-averaged.
- Net assets to total assets
- -10.33%2025
- Reported net assets divided by reported total assets, for the latest year both were filed. Shows how much of the asset base is not financed by liabilities.
- Liabilities to total assets
- 110.33%2025
- Total liabilities divided by reported total assets, for the latest year both were available. Shows how much of the asset base is funded by obligations.
Financial history
Every indicator Okredo tracks, year by year.
Reported financial indicators for UTILIGENSIA LIMITED by year. Amounts are as filed; a dash means the figure was not reported for that year.
| Indicator | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Net Assets£ | 101.75K | 47.20K | 20.06K | 7.26K | -13.13K |
| Total Assets£ | 166.54K | 78.85K | 71.58K | 61.92K | 127.07K |
| Cash in Bank£ | – | – | – | – | – |
| Total Liabilities£ | 64.80K | – | – | 54.65K | 140.19K |
| Employees | 3 | 4 | 5 | 0 | 0 |
UTILIGENSIA LIMITED financials: frequently asked questions
Answered from this company's own filed figures.
Yes. Okredo holds filed figures for UTILIGENSIA LIMITED covering 2021–2025, across 4 reported indicators. The most recent reported year is 2025.
UTILIGENSIA LIMITED reported net assets of £-13.13K for 2025. That compares with £7.26K in 2024, a change of -280.69%.
UTILIGENSIA LIMITED reported total assets of £127.07K for 2025. That compares with £61.92K in 2024, a change of 105.23%.
UTILIGENSIA LIMITED reported total liabilities of £140.19K for 2025. That compares with £54.65K in 2024, a change of 156.52%.
UTILIGENSIA LIMITED reported 0 employees in 2025, compared with 0 in 2024.
Between 2023 and 2025, UTILIGENSIA LIMITED's net assets fell by 165%, total assets rose by 77.5% and employee numbers fell by 100%. Total assets compounded at 33.2% a year across the two years to 2025, from £71.58K to £127.07K. Reported headcount went from 5 in 2023 to 0 in 2025 (-5).
Okredo holds reported figures for the years 2021, 2022, 2023, 2024, 2025. Where an indicator was not reported for a given year, the financial history table shows a dash rather than a value.